On (b)(6) 2020, a patient on peritoneal dialysis (pd) reported having a pd catheter (not a fresenius product) exit site infection on (b)(6) 2020.It was reported the patient had a 21-day course of antibiotics.The patient stated the infection was unrelated to the use of any fresenius product(s) or device(s).The patient's nurse reported the infection was caused by moisture at the exit site.During additional follow-up, the patient confirmed the event.Based on the available information, there is no allegation or indication that a fresenius device or product issue caused or contributed to a serious patient harm or injury.(b)(4).This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|